Trials / Completed
CompletedNCT03525912
Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions
Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions: a Prospective Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Universidad de Antioquia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of neuropsychiatric and cardiovascular side effects of low dose ketamine analgesic infusion for postoperative pain
Detailed description
Postoperative pain is a world wide problem related with surgery. Multimodal analgesia may include ketamine, aimed to decrease opioid adverse effects in postoperative analgesia for major surgery, and risk of chronic postsurgical pain. Ketamine has shown efficacy as adjuvant in multimodal analgesia, however, neuropsychiatric and cardiovascular effects of ketamine at low doses in continue postoperative infusion are less known. This type of adverse effects may compromise appropriated recovery. Objective to determine frequency of delirium, agitation, sedation, hallucinations, bad dreams and cardiovascular changes associated with ketamine analgesic infusion treatment for postoperative pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | continuous infusion of low dose ketamine for postoperative pain |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2018-03-31
- Completion
- 2018-11-14
- First posted
- 2018-05-16
- Last updated
- 2019-03-28
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT03525912. Inclusion in this directory is not an endorsement.